Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

NCT04322682 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT04322682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Lead sponsor
Montreal Heart Institute
Phase
Phase 3
Overall status
Terminated
Start date
March 23, 2020
Completion date
January 21, 2021
Enrollment
4,506 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection